Covid vaccine: Nod for human trials marks beginning of end, says Centre

NEW DELHI: As India races to develop a vaccine for Covid-19, the government on Sunday said that the country is entering the human trial stage which “marks the beginning of the end” of the pandemic.

Covid-19 vaccine candidate Covaxin, developed by the Hyderabad-based Bharat Biotech International Limited (BBIL) in collaboration with the ICMR and the National Institute of Virology (NIV), had recently got the nod for human clinical trials from the Drug Controller General of India (DCGI).

Talking about how Covaxin works, the ministry explained, “The Bharat Biotech’s COVAXIN uses the virus isolated from an Indian patient by the National Institute of Vi